fbpx

Inexpensive, Non-Toxic, Effective Ulcerative Colitis Therapy

Share Button

 “Treatment of patients with mild to moderate Ulcerative Colitis, not responding to conventional therapy, with VSL#3 resulted in a combined induction of remission/response rate of 77% with no adverse events”

Evidence-based research coupled with actionable therapy information. I launched PeopleBeatingCancer in ’04 thinking that I would do the above for cancer patients. However my research into therapies such as probiotics, curcumin, resveritrol, vitamin D3, etc. have shown that I can provide both evidence-based research (see below) and actionable therapy information to people who suffer from chronic diseases such as ulcerative colitis (UC) as well.

color xray of ulcerative colitis

For the record I’m not trying to offer an either/or, conventional/non-conventional proposition. I am offering research into integrative or complimentary therapies not discussed in your primary care physician’s office.

I take a broad spectrum probiotic supplement. Specific strains of probiotics benefit specific health issues. The study below supports VSL#3 High Potency Probiotic Capsules putting active ulcerative colitis patients into remission. 

For more information about integrative therapies that may support UC patients, scroll down the page, post a question or comment and I will reply ASAP.

thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.

“BACKGROUND AND AIMS: Intestinal bacteria have been implicated in the initiation and perpetuation of IBD; in contrast, “probiotic bacteria” have properties possibly effective in treating and preventing relapse of IBD. We evaluated the safety and efficacy of VSL#3 and the components, and the composition of the biopsy-associated microbiota in patients with active mild to moderate ulcerative colitis (UC)…

Conclusion: Treatment of patients with mild to moderate UC, not responding to conventional therapy, with VSL#3 resulted in a combined induction of remission/response rate of 77% with no adverse events. At least some of the bacterial species incorporated in the probiotic product reached the target site in amounts that could be detected.”

 

Leave a Comment:

1 comment
Ulceritive Colitis integrative therapies - PeopleBeatingCancer says 7 years ago

[…] Active Ulcerative Colitis Treatment […]

Reply
Add Your Reply